People People

People

Louis Delvaux Baker Botts Brussels
Louis Delvaux Baker Botts Brussels
Louis Delvaux
louis.delvaux@bakerbotts.com
DETAILS
Practices
Antitrust and Competition Law
Antitrust Consumer Products
Litigation
Details
Overview
Overview Admissions & Affiliations Experience Thought Leadership
Practices
Antitrust and Competition Law
Antitrust Consumer Products
Litigation

Overview

Louis Delvaux is an associate in the Antitrust and Competition Practice of Baker Botts’ Brussels office.

His practice specializes in EU and UK competition law, with a focus on merger control and behavioral investigations conducted by the European Commission and the UK's Competition and Markets Authority (CMA). Louis advises clients on complex transactions involving international merger control laws, as well as matters related to the EU Foreign Subsidies Regulation and Foreign Direct Investment control.

Louis has guided clients across a diverse range of industries, including pharmaceuticals, private equity, energy, automotive, semiconductor and chemicals, providing strategic legal guidance and navigating intricate regulatory frameworks. He also advises clients on competition law compliance.

Louis also advises clients in complaints to the EU Commission, the UK CMA and EU Member States competition authorities. He has also advises clients on exposure to Article 101 and 102 TFEU, in relation to their pricing, commercial or distribution strategies.

Featured Experience

 

 

 

Admissions & Affiliations

  • Brussels Bar, French Speaking Section

Education

  • LL.M., Universidad Carlos III de Madrid 2020
  • Master in International Public Law, Université libre de Bruxelles 2018

Experience

  • Representing a global financial services company and its partner before the UK CMA for the acquisition of a leading vehicle leasing company.*
  • Representing a private equity firm for the acquisition of a cybersecurity company.*
  • Representing the same private equity firm for the acquisition of a new portfolio company.*
  • Representing a UK-based investment firm before the UK CMA for the acquisition of an automotive parts distributor.*
  • Representing an investment firm in the re-investment in a pharmaceutical company for FDI matters.*
  • Representing a financial services group before the UK CMA for the sale of its wealth management business to a leading financial group.*
  • Representing a global manufacturing company in its acquisition of a components manufacturer for FDI matters.*
  • Advising a group of companies on the acquisition of businesses in Australia and New Zealand, including clean team arrangements.*
  • Advising an asset management firm on the acquisition of a fund by a major global investment manager.*
  • Advising a financial services company on the sale of three investment funds.*
  • Representing a global security services provider in a cartel investigation by the Belgian Competition Authority.*
  • Representing an international tire manufacturer in a cartel investigation by the UK CMA.*
  • Representing a pharmaceutical company in the Hydrocortisone proceedings before the UK Competition Appeal Tribunal.*

*Prior to joining Baker Botts